0001209191-19-044010.txt : 20190801
0001209191-19-044010.hdr.sgml : 20190801
20190801161202
ACCESSION NUMBER: 0001209191-19-044010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190730
FILED AS OF DATE: 20190801
DATE AS OF CHANGE: 20190801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOYLE WILLIAM F
CENTRAL INDEX KEY: 0001194459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19992796
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-30
0
0001645113
NovoCure Ltd
NVCR
0001194459
DOYLE WILLIAM F
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
1
0
0
Executive Chairman
Restricted Stock Units
2019-07-30
4
A
0
6002
0.00
A
852465
D
Options to Buy Ordinary Shares
83.30
2019-07-30
4
A
0
10412
0.00
A
2029-07-30
Ordinary Shares
10412
10412
D
These equity awards were granted to Mr. Doyle in recognition of his accomplishments related to Medicare coverage and pricing.
One-third of these restricted stock units are scheduled to vest on each of July 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates.
Options to buy 10,412 ordinary shares will vest and become exercisable in equal installments on each of July 30, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates.
By: /s/ Kimberly Burke, Attorney in Fact for William F. Doyle
2019-08-01